Operating Margin in % of Rani Therapeutics Holdings, Inc. from 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Rani Therapeutics Holdings, Inc. quarterly and annual Operating Margin history and change rate from 2020 to Q3 2025.
  • Rani Therapeutics Holdings, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -3,728%.
  • Rani Therapeutics Holdings, Inc. annual Operating Margin for 2024 was -5,186%.
  • Rani Therapeutics Holdings, Inc. annual Operating Margin for 2021 was -1,899%, a 47% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Rani Therapeutics Holdings, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -3,728% 01 Jul 2025 30 Sep 2025
Q2 2025 -4,106% 01 Apr 2025 30 Jun 2025
Q1 2025 -4,274% 01 Jan 2025 31 Mar 2025
Q4 2024 -5,186% 01 Oct 2024 31 Dec 2024
Q4 2021 -1,899% 01 Oct 2021 31 Dec 2021

Rani Therapeutics Holdings, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -5,186% 01 Jan 2024 31 Dec 2024
2021 -1,899% +1,682% +47% 01 Jan 2021 31 Dec 2021
2020 -3,581% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.